Short answer
FATE THERAPEUTICS INC (FATE) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 and full-year 2025 financial results released Feb 26, 2026.
FATE THERAPEUTICS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 financial results released Feb 26, 2026
- Specific figures (revenue, earnings, cash position) contained in Exhibit 99.1 press release
- Fate is a clinical-stage cell therapy company: results likely reflect R&D spend vs. minimal product revenue
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other FATE THERAPEUTICS INC 8-K filings
Get the next FATE 8-K as it lands
Follow FATE for push alerts, or ask the research agent what this filing means.